Department of Biochemistry

November 17, 2016

Graduate student’s cancer studies land NCI support

Kamakoti “Kami” Bhat, a fifth-year graduate student in the lab of David Cortez, Ph.D., professor of Biochemistry in the School of Medicine, has achieved a “first” for Vanderbilt University.

By Bill Snyder
October 21, 2016

DNA damage response protein

Vanderbilt researchers have determined that a previously uncharacterized protein responds to DNA replication stress and has an essential role in maintaining the integrity of the genome.

By Bill Snyder
October 12, 2016

Imaging probe for retinal disease

An imaging probe developed at Vanderbilt detects retinal inflammation early and may allow therapeutic intervention to prevent blindness.

By Leigh MacMillan
October 6, 2016

Basic science, extraordinary impact

The discoveries that can change the course of human health forever often begin in the tiniest places: in molecules and cells, at the most fundamental intersection of physics, chemistry and biology. Understanding how these cellular and molecular processes work is the focus of basic biomedical research at Vanderbilt.

By Liz Entman and Melanie Moran
Five week old sleeping boy and girl fraternal twin newborn babies. They are wearing crocheted pink and blue striped hats.
September 15, 2016

Study reveals new clues to cystic fibrosis ‘gender gap’

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”

By Bill Snyder
September 9, 2016

In search of new cancer targets

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

By Leigh MacMillan
July 21, 2016

Osheroff to direct Academy for Excellence in Education

Neil Osheroff, Ph.D., has been named director of the Academy for Excellence in Education. He succeeds Lillian Nanney, Ph.D., who served as director since the Academy’s inception in 2007.
By Kathy Whitney
June 23, 2016

VU takes key role in cancer drug discovery consortium

Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery.
By Leigh MacMillan
May 26, 2016

Precision medicine already changing cancer treatment strategies

The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment.
By VUMC News and Communications
May 19, 2016

VICC investigators in spotlight at AACR conference

A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.
By VUMC News and Communications
April 27, 2016

Public invited to learn about VICC precision cancer medicine

Leading cancer investigators from Vanderbilt-Ingram Cancer Center will unveil the latest in cancer research during a community event May 10.
By VUMC News and Communications
April 20, 2016

How strep grabs on to platelets

New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.
By VUMC News and Communications
April 15, 2016

Mechanism of a DNA repair protein

Vanderbilt investigators have discovered details about the mechanism of an important DNA repair protein that maintains genome stability.
By Sanjay Mishra
1 … 7 8 9 10 11 … 15